BACE1
-
Official Full Name
beta-site APP-cleaving enzyme 1 -
Overview
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimers disease. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein (APP) by two proteases, one of which is the protein encoded by this gene. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease that is found mainly in the Golgi. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011] -
Synonyms
BACE1;beta-site APP-cleaving enzyme 1;ASP2;BACE;HSPC104;beta-secretase 1;asp 2;memapsin-2;APP beta-secretase;aspartyl protease 2;beta-site APP cleaving enzyme 1;beta-secretase 1 precursor variant 1;transmembrane aspartic proteinase Asp2;membrane-associated aspartic protease 2;beta-site amyloid beta A4 precursor protein-cleaving enzyme
Recombinant Proteins
- Human
- Mouse
- Zebrafish
- Rhesus macaque
- Rat
- Mus musculus
- HEK293
- E.coli
- Baculovirus
- Wheat Germ
- Mammalian Cell
- Human Cell
- HEK293T
- E. coli
- E.coli expression system
- Fc
- His
- Non
- GST
- Flag
- His&GST
- Myc&DDK
- His&Fc&Avi
Background
What is bace1 protein?
BACE1, or Beta-Secretase 1, is an enzyme that plays a crucial role in the formation of amyloid beta, a protein heavily implicated in the pathology of Alzheimer's disease. BACE1 is involved in the amyloidogenic pathway, where it cleaves the amyloid precursor protein (APP) at the beta-site, leading to the production of amyloid beta peptides.
Amyloid beta peptides can aggregate to form insoluble fibrils and plaques in the brain, which are characteristic features of Alzheimer's disease. These plaques are believed to disrupt cell-to-cell communication and activate immune system cells that trigger inflammation and devour disabled cells.
Inhibiting the activity of BACE1 has been a target for Alzheimer's disease therapy, aiming to reduce the production of amyloid beta and hence its accumulation in the brain. However, developing effective and safe BACE1 inhibitors has been challenging due to the enzyme's other roles in the body and the complex nature of Alzheimer's disease.
What is the function of bace1 protein?
Cleaving Amyloid Precursor Protein (APP): BACE1 cleaves APP at the beta-site. This cleavage is the first step in the production of amyloid beta peptides. After BACE1 cleaves APP, another enzyme, gamma-secretase, further processes the resulting fragments to produce amyloid beta peptides.
Role in Amyloid Beta Peptide Formation: The amyloid beta peptides formed by the action of BACE1 and gamma-secretase can accumulate and form insoluble fibrils and plaques in the brain, which are hallmarks of Alzheimer's disease. These plaques are believed to disrupt neuronal communication, contribute to neuronal death, and trigger inflammatory responses in the brain.
Implications in Alzheimer's Disease: Due to its role in amyloid beta production, BACE1 is a significant target for Alzheimer's disease research. Inhibiting BACE1 activity is considered a potential therapeutic strategy to reduce amyloid beta levels and mitigate the progression of Alzheimer's disease.
Other Biological Roles: Beyond its role in the production of amyloid beta, BACE1 is involved in other biological processes. It cleaves other protein substrates and is involved in myelination and neuronal development. These additional roles of BACE1 highlight the complexity of targeting it for therapeutic purposes, as inhibiting BACE1 could have unintended effects beyond reducing amyloid beta production.
Bace1 related signaling pathway
Amyloid Precursor Protein (APP) Processing:
APP, a transmembrane protein, can undergo processing through two distinct pathways: the non-amyloidogenic pathway and the amyloidogenic pathway. The non-amyloidogenic pathway involves the cleavage of APP by α-secretase, which precludes the formation of amyloid beta. In the amyloidogenic pathway, APP is first cleaved by β-secretase, of which BACE1 is a key enzyme.
Role of BACE1:
BACE1 cleaves the extracellular portion of APP at the beta-site, producing a soluble fragment (sAPPβ) and a membrane-bound fragment (C99). This cleavage by BACE1 is the initial step in the amyloidogenic pathway and is crucial for the subsequent production of amyloid beta peptides.
Further Processing by γ-Secretase:
The C99 fragment left in the membrane after BACE1 cleavage is then processed by γ-secretase. γ-Secretase cleaves this fragment to release amyloid beta peptides of varying lengths, with amyloid beta 40 and amyloid beta 42 being the most common forms.
Bace1 Related Diseases
Alzheimer's Disease (AD):
The most well-known association of BACE1 is with Alzheimer's disease. BACE1 is involved in the initial step of the amyloidogenic pathway, cleaving the amyloid precursor protein (APP) and leading to the production of amyloid beta (Aβ) peptides. Accumulation of Aβ peptides, particularly Aβ42, leads to the formation of amyloid plaques, a hallmark of Alzheimer's pathology. These plaques contribute to neurodegeneration and the cognitive decline seen in Alzheimer's patients.
Cerebral Amyloid Angiopathy (CAA):
CAA is a condition characterized by the deposition of amyloid beta in the walls of the cerebral arteries. This condition can lead to cerebral hemorrhage and is often found in Alzheimer's disease patients. Since BACE1 is involved in the production of amyloid beta, its activity is also associated with the pathogenesis of CAA.
Down Syndrome:
Individuals with Down Syndrome (trisomy 21) have an extra copy of chromosome 21, which includes the APP gene. Overexpression of APP can lead to increased production of amyloid beta due to more substrate being available for BACE1. This is one reason why individuals with Down Syndrome are at a higher risk of developing early-onset Alzheimer's disease.
Biomedical Application of bace1 Protein
- BACE1 Inhibitors: Given its crucial role in the production of amyloid beta peptides, BACE1 is a major target for Alzheimer's disease drug development. Inhibitors of BACE1 aim to reduce the production of amyloid beta, potentially slowing the progression of Alzheimer's disease. Several BACE1 inhibitors have been developed and tested in clinical trials.
- Disease Modification: By targeting a key step in the amyloidogenic pathway, BACE1 inhibitors could potentially modify the course of Alzheimer's disease, rather than merely treating symptoms. This represents a significant shift in the therapeutic approach to this condition.
- Diagnostic Tool: Changes in BACE1 activity or levels in the body could serve as biomarkers for the early detection of Alzheimer's disease. Research is ongoing to determine if measuring BACE1 activity in blood or cerebrospinal fluid can provide a reliable diagnostic tool.
Case Study
(Katherine R Sadleir, 2015)
Fig2. BACE1 levels are reduced by ~50% in 5XFAD/BACE1 +/− mice. (A) 20 μg of protein/lane of brain homogenates of 4, 6, and 9 month-old 5XFAD/BACE1+/+, 5XFAD/BACE1+/− or 5XFAD/BACE1−/− (as a negative control) female (F) and male (M) mice were separated by SDS-PAGE, transferred onto PVDF membrane, stained with Ponceau S, and incubated with BACE-Cat1 monospecific antibody against BACE1 [28] followed by HRP-conjugated secondary antibody and chemiluminescence imaging. Representative BACE1 immunoblot and Ponceau S staining of brain homogenates from 4 month-old mice is shown. Note the absence of BACE1 immunosignal in the BACE1−/− lane.
(Kiyoko S. Murayama , 2005)
Fig3. Analysis of BACE1 shedding and extracellular release of BACE1 holoproteins. Immunoblot analysis of the BACE1 CTF. Membrane proteins from SH-BA cells were separated on 16% Tris–Tricine gels and immunoblotted with a mouse monoclonal 1D4 antibody
Quality Guarantee
High Purity
Fig1. SDS-PAGE (Cat. No.: BACE1-891H)
Involved Pathway
BACE1 involved in several pathways and played different roles in them. We selected most pathways BACE1 participated on our site, such as Alzheimers disease, which may be useful for your reference. Also, other proteins which involved in the same pathway with BACE1 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|---|
Alzheimers disease | COX7B2,UQCRH,TNF,APOE,APAF1,CDK5,ATP5C1,NDUFS4,COX7C,CAPN2 |
Protein Function
BACE1 has several biochemical functions, for example, aspartic-type endopeptidase activity,beta-amyloid binding,beta-aspartyl-peptidase activity. Some of the functions are cooperated with other proteins, some of the functions could acted by BACE1 itself. We selected most functions BACE1 had, and list some proteins which have the same functions with BACE1. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
protein binding | SPATA7,PVRL1,LBH,ADCK5,ZNF695,LEPROT,STK40,MRPL15,SOX1,ENTPD3 |
beta-amyloid binding | MAPK8IP2,APOEB,TSSK1B,CHRNA7,ARMCX5-GPRASP2,GPRASP2,APOEA,HSD17B10,CLSTN1,APBB2 |
peptidase activity | ADAM25,OTUD5A,SPINT1A,MMP23BB,PCSK7,GZMF,USP12A,BMP1,NOTS,FURINB |
aspartic-type endopeptidase activity | REN,BACE2,DDI1,ATP6AP2,ASPRV1,Casp3,SPPL3,CNTNAP5A,PIP,PGC |
enzyme binding | TAF10,SLC12A3,PRMT1,PRKCD,PRKCH,DDC,HLCS,KRT79,ZFHX3,CAT |
Interacting Protein
BACE1 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with BACE1 here. Most of them are supplied by our site. Hope this information will be useful for your research of BACE1.
Clec4g;FLOT2;APP;Flot1;FLOT1;MMP2;CSNK1D;App
Resources
Related Services
Related Products
References
- Sadleir, KR; Eimer, WA; et al. A beta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Molecular Neurodegeneration 10:-(2015).
- Yu, YJ; Atwal, JK; et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. SCIENCE TRANSLATIONAL MEDICINE 6:-(2014).